Department of Pathological Anatomy

Medicine & Life Sciences

1. Adenocarcinoma 11%
2. Anti-Inflammatory Agents 8%
3. antimycin 8%
4. Apoptosis 15%
5. B-Lymphocytes 7%
6. Basal Cell Carcinoma 7%
7. Biopsy 13%
8. Blood Cells 6%
9. Bone and Bones 16%
10. Breast 6%
11. Breast Neoplasms 42%
12. Cadherins 6%
13. Cancer Care Facilities 6%
14. Cancer-Associated Fibroblasts 6%
15. Carcinogenesis 10%
16. Carcinoma 20%
17. Case-Control Studies 8%
18. Caspase 3 14%
19. Catenins 11%
20. Cell Biology 11%
21. Cell Line 15%
22. Cell Proliferation 7%
23. Chitosan 7%
24. Chronic Hepatitis B 7%
25. Colon 15%
26. Colonoscopy 5%
27. Colorectal Neoplasms 21%
28. Contraceptive Agents 6%
29. Control Groups 11%
30. Cross-Sectional Studies 5%
31. Cyclooxygenase 2 8%
32. Dextran Sulfate 17%
33. DNA 6%
34. Drug Therapy 8%
35. Ductal Carcinoma 8%
36. Embryonal Rhabdomyosarcoma 7%
37. Endometrioid Carcinoma 7%
38. Endometrium 6%
39. Eosine Yellowish-(YS) 6%
40. Epidemiologic Studies 7%
41. Epidemiology 6%
42. Ethanol 8%
43. Fas Ligand Protein 6%
44. Fetal Blood 6%
45. Fibrosis 8%
46. Fruit 7%
47. General Hospitals 6%
48. Genes 7%
49. Hepatocellular Carcinoma 9%
50. Human Herpesvirus 4 13%
51. Immunohistochemistry 18%
52. Incidence 6%
53. Indonesia 100%
54. Inflammation 9%
55. Japan 14%
56. Keratin-19 7%
57. Limb Salvage 6%
58. Liposarcoma 6%
59. Liver 10%
60. Lymph Nodes 12%
61. Lymphocytes 7%
62. Lymphoma 15%
63. Lymphoma, Large B-Cell, Diffuse 7%
64. Melanoma 9%
65. Mesenchymal Stem Cells 8%
66. Messenger RNA 5%
67. Middle Cerebral Artery Infarction 6%
68. Mitosis 6%
69. Mutation 9%
70. Natural Killer Cells 7%
71. Neoplasm Metastasis 19%
72. Neoplasms 38%
73. NF-kappa B 6%
74. Nitric Oxide Synthase Type II 5%
75. norethindrone enanthate 5%
76. nucleolar organizer region associated proteins 7%
77. Osteosarcoma 9%
78. Ovarian Epithelial Carcinoma 6%
79. Paraffin 9%
80. Pathology 8%
81. Pleural Empyema 14%
82. Polyps 6%
83. Population 7%
84. Proteins 12%
85. Recurrence 6%
86. Sarcoma 6%
87. Sensitivity and Specificity 6%
88. Skin 7%
89. Skin Neoplasms 17%
90. Sprague Dawley Rats 8%
91. Squamous Cell Carcinoma 14%
92. Staining and Labeling 16%
93. Survival 9%
94. T-Cell Lymphoma 6%
95. T-Lymphocytes 6%
96. Therapeutics 9%
97. Uterine Cervical Neoplasms 29%
98. Wistar Rats 7%
99. Wound Healing 5%
100. Wounds and Injuries 6%